Does INFLIXIMAB Cause Hypercholesterolaemia? 1,338 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,338 reports of Hypercholesterolaemia have been filed in association with INFLIXIMAB (Renflexis). This represents 1.0% of all adverse event reports for INFLIXIMAB.
1,338
Reports of Hypercholesterolaemia with INFLIXIMAB
1.0%
of all INFLIXIMAB reports
1,145
Deaths
846
Hospitalizations
How Dangerous Is Hypercholesterolaemia From INFLIXIMAB?
Of the 1,338 reports, 1,145 (85.6%) resulted in death, 846 (63.2%) required hospitalization, and 901 (67.3%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 1,338 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
CERTOLIZUMAB PEGOL (1,321)
Which INFLIXIMAB Alternatives Have Lower Hypercholesterolaemia Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT